Pemilihan Pemeriksaan Imaging untuk Skrining Karsinoma Mammae

Authors

  • Andrey Gunawan Alumnus Fakultas Kedokteran Universitas Kristen Maranatha, Bandung, Indonesia

DOI:

https://doi.org/10.55175/cdk.v48i6.86

Keywords:

imaging, kanker payudara, skrining

Abstract

Di seluruh dunia, kanker payudara adalah kanker yang paling sering didiagnosis dan penyebab utama kematian akibat kanker di kalangan wanita. Risiko terkena karsinoma mammae pada wanita sebesar 12,2%. Oleh karena itu, skrining karsinoma mammae pada wanita usia produktif sebaiknya dilakukan sedini mungkin. Mammografi tetap menjadi pilihan utama imaging untuk skrining karsinoma mammae. Pada kasus payudara padat, USG mungkin dapat membantu diagnosis. MRI merupakan modalitas tambahan, dan memiliki sensitivitas tinggi bila digabung dengan mammografi dan pemeriksaan klinis, namun tingginya biaya pemeriksaan MRI perlu menjadi pertimbangan.

Breast cancer is the most frequently diagnosed life-threatening cancer in women and the leading cause of cancer death among women worldwide. Women have 12.2% risk for developing breast carcinoma. Screening for breast carcinoma in reproductive women should be done as early as possible. Mammography remains the modality of choice for screening. In case of dense breasts, ultrasound may help the diagnosis. MRI is an additional modality, and has a high sensitivity when combined with mammography and clinical examination, but the high cost of MRI examination needs to be considered.

Downloads

Download data is not yet available.

References

Pavani Chalasani MM, Chief Editor: John V Kiluk MF. Breast cancer clinical presentation. [Internet]. 2020 [cited 2020]. Available from: https://emedicine.medscape.com/article/1947145-clinical.

Brunicardi FC, Andersen DK, Biliar TR, Dunn DL, Hunter JG. Schwartz principle of Surgery. Mc Graw Hill; 2019.

Kemenkes. Nasional KPK. 2010

Courtney M, Townsend JM, et al. Sabiston textbook of surgery. Elsevier; 2017.

WHO. EHO [Internet]. 2018 [cited 2020]. Available from: https://www.who.int/cancer/country-profiles/IDN_2020.pdf?ua=1 .

Breast Cancer Facts and Figures 2017-2018. American Cancer Society. Breast Cancer Facts & Figures 2017-2018. Atlanta; 2017.

CDC. [Internet]. 2018 [cited 2020]. Available from: https://www.cdc.gov/cancer/breast/pdf/breastcancerscreeningguidelines.pdf .

Guraya Y. Breast cancer screening: Implications and clinical perspectives. 2008;3(2):67-79.

Amera Abd Elsalam Mostafa MAE. Automated breast ultrasound (ABUS) as a screening tool: Initial experience. Egyptian J Radiol Nuclear Med. 2019;50(1):1-6.

Baron RM, Drucker KM, Lagdamen LM, Cannon MM, Mancini CM, Fischer-Cartlidge ED. Breast cancer screening: A review of current guidelines. 2018;118(7):34-41.

JM. Seely M, T Alhassan M. Screening for breast cancer in 2018. Current Oncology. 2018;25(1):115-24.

Alan Hollingsworth M. Position statement on screening mammograph. 2019.

Schünemann HJ, Lerda D, Quinn C, Follmann M, Alonso-Coello P, Rossi PG, et al. Breast cancer screening and diagnosis: A synopsis of the European breast guidelines. European Commision Initiative on Breast Cancer. 2020;172(1):46-56.

Gagnon J, Lévesque E, Borduas F, Chiquette J, Diorio C, Duchesne N, et al. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: Impending changes to current policies. Curr Oncol. 2016;23(6):615-25.

USPSTF. Breast cancer screening [Internet]. 2016 [cited 2020]. Available from: https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breastcancer-screening.

IARC. Handbooks of cancer prevention. 15th Ed. Lyon: International Agency for Research on Cancer; 2016.

Downloads

Published

02-06-2021

How to Cite

Gunawan, A. (2021). Pemilihan Pemeriksaan Imaging untuk Skrining Karsinoma Mammae. Cermin Dunia Kedokteran, 48(6), 347–349. https://doi.org/10.55175/cdk.v48i6.86

Issue

Section

Articles